Ovarian Cancer News and Research

RSS
Commonly known as the "silent killer," ovarian cancer leads to approximately 15,000 deaths each year in the United States, according to the American Cancer Society. Approximately 20,000 new cases are diagnosed each year, with the majority in patients diagnosed with late stage disease where the cancer has spread beyond the ovary. The prognosis is poor in these patients, leading to the high mortality from this disease. A diagnostic test is needed that can provide adequate predictive value to stratify patients with a pelvic mass into high risk of invasive ovarian cancer versus those with low risk, as well as a screening test for the diagnosis of early-stage ovarian cancer, which is essential for improving overall survival in patients. Ovarian cancer has up to a 90% cure rate following surgery and/or chemotherapy if detected in stage 1.
Cedars-Sinai surgeons detect and remove 25-pound cancerous ovarian tumor

Cedars-Sinai surgeons detect and remove 25-pound cancerous ovarian tumor

Secondary surgery for recurrent ovarian cancer patients does not result in longer survival

Secondary surgery for recurrent ovarian cancer patients does not result in longer survival

Experimental drug targets currently untreatable type of lung cancer

Experimental drug targets currently untreatable type of lung cancer

Oxygen-deprived tumor cells have survival advantage that promotes metastasis

Oxygen-deprived tumor cells have survival advantage that promotes metastasis

Nanotechnologies can lead to big advances in cancer therapy

Nanotechnologies can lead to big advances in cancer therapy

3D-printed cell traps help researchers remove the hay to expose cancer cells

3D-printed cell traps help researchers remove the hay to expose cancer cells

Genetically definable subgroups of cancers sensitive to treatment

Genetically definable subgroups of cancers sensitive to treatment

Cooperative research center at LLNL aims to develop vaccines for chlamydia

Cooperative research center at LLNL aims to develop vaccines for chlamydia

Cleveland Clinic announces Top 10 Medical Innovations for 2020

Cleveland Clinic announces Top 10 Medical Innovations for 2020

Yale scientists build powerful genomic research platform to study cervical cancer

Yale scientists build powerful genomic research platform to study cervical cancer

Chemists find new way to synthesize most common molecule arrangement in medicine

Chemists find new way to synthesize most common molecule arrangement in medicine

Marshall receives $17 million renewal funding for biomedical research efforts in West Virginia

Marshall receives $17 million renewal funding for biomedical research efforts in West Virginia

Combination of two drugs disrupts cancer cells' ability to survive DNA damage, study finds

Combination of two drugs disrupts cancer cells' ability to survive DNA damage, study finds

New UW center awarded NIH funding to improve prevention and detection of cancer

New UW center awarded NIH funding to improve prevention and detection of cancer

Multi-gene testing at point of diagnosis can save all women with breast cancer

Multi-gene testing at point of diagnosis can save all women with breast cancer

Innovative compound kills cancer cells, minimizes damage to normal tissues

Innovative compound kills cancer cells, minimizes damage to normal tissues

Targeted therapy slows disease progression and improves survival for prostate cancer

Targeted therapy slows disease progression and improves survival for prostate cancer

Domestic violence may affect mothers' breastfeeding practices in developing countries

Domestic violence may affect mothers' breastfeeding practices in developing countries

Breast, ovarian cancer drug more effective than targeted hormone therapy in some men with prostate cancer

Breast, ovarian cancer drug more effective than targeted hormone therapy in some men with prostate cancer

Intensive new combination therapy for ovarian cancer shows promising results

Intensive new combination therapy for ovarian cancer shows promising results